coagulation profile of septic patients under real time monitoring by thromboelastography

Antithrombin III and activated protein C for the treatment of severe sepsis associated to coagulopathy

the expression of innate immunity and coagulative response in acute lung injury. septic verus non septic patients.

MODIFICATION OF COAGULATION IMBALANCE DURING ANTITHROMBIN TREATMENT IN PREECLAMPTIC PATIENTS: OUR EXPERIENCE

Preeclamptic conditions are often associated with a natural inhibitor consumption. Many studies have evidenced validity of antithrombin (AT) treatment during preeclamptic conditions. The aim of the study is to restore a congruous coagulation imbalance with administration of AT under the guide of thromboelastographic monitoring (TEG).

Epidemiologia e microbiologia del cateterismo venoso centrale in una UTI polivalente: cateteri non medicati vs cateteri medicati.

La risposta immune neella insufficienza respiratoria acuta in terapia intensiva: correlazione tra scores clinici e markers bioumorali

Modifications of coagulation imbalance during antithrombin treatment in preeclamptic patients

Profilassi Antitrombotica con Fondaparinux vs Eparina a Basso Peso Molecolare. Monitoraggio Mediante Tromboelastogramma (TEG).

Epidemiologia e microbiologia del cateterismo venoso centrale in una UTI polivalente: cateteri non medicati vs medicati